Upcoming Webinar: Neuroendocrine Tumors

April 10, 2018 Time: 3:00pm EDT Presenter: Heather Westendorf, PharmD, RPh Advanced Accelerator Applications

In this session, Dr. Westendorf will:

  • Detail the incidence, prevalence and survival rates for patients with neuroendocrine tumors (NETs)
  • Review the current treatment regimens for NETs, the clinical questions for oncologists and the challenges to diagnosis
  • Discuss the role of somatostatin-receptor imaging (SSRI) and peptide receptor radionuclide therapy (PRRT) in the management of NETs
  • Identify the key data from Phase II and III clinical trials of Lu- 177 Dotatate
  • Review the elements of Lu-177 Dotatate Treatment and Administration

Register now: https://attendee.gotowebinar.com/register/4370827389111774466